Engerix

Engerix is a vaccine designed to prevent hepatitis B, a viral infection affecting the liver. It contains hepatitis B surface antigen (rDNA) and is administered via intramuscular or subcutaneous injection.

Engerix is primarily used for the prevention of hepatitis B infection. It is recommended for individuals at risk of exposure to the virus, such as healthcare workers, travelers to regions with high infection rates, and those with chronic liver disease. The vaccine works by stimulating the body's immune response to develop protection against the hepatitis B virus.

Common effects of Engerix may include soreness, redness, or swelling at the injection site. Some individuals might experience mild fever, headache, or fatigue following vaccination. These effects are usually temporary and resolve on their own within a few days.

Engerix should be administered with caution in individuals with a history of severe allergic reactions to any component of the vaccine. It is important to inform healthcare providers about any allergies or medical conditions before receiving the vaccine. Pregnant or breastfeeding women should consult their healthcare provider before vaccination.

Engerix may interact with certain medications that affect the immune system. It is advisable to discuss all current medications with a healthcare provider before receiving the vaccine. Additionally, individuals with weakened immune systems may have a reduced response to the vaccine.